DoximityNYSE: DOCS

Doximity (DOCS) closed the most recent trading day at $27.97, moving +0.5% from the previous trading session.

Dr Martens PLC (LSE:DOCS) stock market rating is on something of a knife edge with analysts at Barclay's keen for visibility over the boot maker's direct-to-consumer sales channel. A less than emphatic recent trading update leaves investors guessing in regards to the company's prospects for the rest of the year.

NEW YORK, NY / ACCESSWIRE / June 17, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Doximity, Inc. ("Doximity" or "the Company") (NYSE: DOCS) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Doximity securities between February 9, 2022 and April 1, 2024, inclusive (the "Class Period").

NEW YORK, NY / ACCESSWIRE / June 17, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Doximity, Inc. ("Doximity" or the "Company") (NYSE:DOCS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

LOS ANGELES--(BUSINESS WIRE)--DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with the Schall Law Firm.

RADNOR, Pa., June 14, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Doximity, Inc. (NYSE: DOCS) (“Doximity” or the “Company”) on behalf of investors who purchased or acquired Doximity common stock between February 9, 2022, and April 1, 2024, inclusive (the “Class Period”). This action, captioned Kissler v. Doximity, Inc., et al., Case No. 3:24-cv-02281-JST was filed in the United States District Court for the Northern District of California.

LOS ANGELES , June 13, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS).

NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

SAN FRANCISCO, CA / ACCESSWIRE / June 13, 2024 / National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Doximity, Inc. ("Doximity" or the "Company") (NYSE:DOCS) who suffered losses from purchasing or otherwise acquiring Doximity common stock between February 9, 2022, and April 1, 2024, inclusive (the "Class Period"), to contact us immediately regarding a pending securities fraud class action against Doximity. The deadline to apply to be lead plaintiff is June 17, 2024.